Guardant Health
GH
#1568
Rank
$13.24 B
Marketcap
$102.02
Share price
-5.99%
Change (1 day)
180.51%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -$0.4 Billion USD

According to Guardant Health 's latest financial reports the company's current earnings are $0.90 Billion USD. In 2024 the company made an earning of -$0.44 Billion USD, an increase over its 2023 earnings that were of -$0.48 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.4 Billion-8.61%
2024 -$0.44 Billion-9.12%
2023 -$0.48 Billion-26.73%
2022 -$0.66 Billion69.96%
2021 -$0.39 Billion56.35%
2020 -$0.25 Billion252.69%
2019 -$69.73 Million-17.22%
2018 -$84.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Natera
NTRA
-$0.31 Billion-22.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-$1.08 Billion 170.04%๐Ÿ‡บ๐Ÿ‡ธ USA